Amedeo's Top 20

Amedeo Smart

Independent Medical Education

15 May 2023

Multidisciplinary Journal Club

  1. Jonas DE, Riley SR, Lee LC, Coffey CP, et al.
    Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA 2023;329:1495-1509.

  1. Mangione CM, Barry MJ, Nicholson WK, Cabana M, et al.
    Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA 2023;329:1487-1494.

  2. Partridge AH, Niman SM, Ruggeri M, Peccatori FA, et al.
    Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
    N Engl J Med 2023;388:1645-1656.

  3. Li D, Jiang SF, Lei NY, Shah SC, et al.
    Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States.
    Gastroenterology 2023.

  4. Gaudino M, Andreotti F, Kimura T.
    Current concepts in coronary artery revascularisation.
    Lancet 2023.

  1. Lisco A, Ortega-Villa AM, Mystakelis H, Anderson MV, et al.
    Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years.
    N Engl J Med 2023;388:1680-1691.

  2. Laws A, Punglia RS.
    Endocrine Therapy for Primary and Secondary Prevention After Diagnosis of High-Risk Breast Lesions or Preinvasive Breast Cancer.
    J Clin Oncol 2023.

  3. Jackson ER, Duchatel RJ, Staudt DE, Persson ML, et al.
    ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
    Cancer Res 2023.

  4. Rognli EB, Heiberg IH, Jacobsen BK, Hoye A, et al.
    Transition From Substance-Induced Psychosis to Schizophrenia Spectrum Disorder or Bipolar Disorder.
    Am J Psychiatry 2023.

  5. Zinzani PLL, Thieblemont C, Melnichenko V, Bouabdallah K, et al.
    Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170.
    Blood 2023.

  1. Yoosuf S, Singh P, Khaitan A, Strand TA, et al.
    Prevalence of Celiac Disease in Patients With Liver Diseases: A Systematic Review and Meta-Analyses.
    Am J Gastroenterol 2023;118:820-832.

  2. Kim J.
    In patients with chronic neuropathic pain, cannabinoids improve sleep and reduce pain vs. placebo.
    Ann Intern Med 2023.

  3. Howell J, Seaman C, Wallace J, Xiao Y, et al.
    Pathway to global elimination of hepatitis B: HBV cure is just the first step.
    Hepatology 2023.

  4. Iranzo A, Mammana A, Munoz-Lopetegi A, Dellavalle S, et al.
    Misfolded alpha-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder.
    Neurology 2023;100:e1944-e1954.

  5. Rusthoven CG, Staley AW, Gao D, Yomo S, et al.
    Comparison of First-Line Radiosurgery for Small-Cell and Non-Small Cell Lung Cancer Brain Metastases (Cross-FIRE).
    J Natl Cancer Inst 2023.

  1. Akinboro O, Drezner N, Amatya A, Runyan J, et al.
    US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung Cancer.
    J Clin Oncol 2023.

  2. Borlaug BA, Sharma K, Shah SJ, Ho JE, et al.
    Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement.
    J Am Coll Cardiol 2023;81:1810-1834.

  3. Fowler VG, Durack DT, Selton-Suty C, Athan E, et al.
    The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.
    Clin Infect Dis 2023.

  4. Inoue K, Guo R, Lee ML, Ebrahimi R, et al.
    Iodine-Induced Hyperthyroidism and Long-term Risks of Incident Atrial Fibrillation and Flutter.
    J Clin Endocrinol Metab 2023.

  5. Kahn JM, Yabes JG, Bukowski LA, Davis BS, et al.
    Intensivist physician-to-patient ratios and mortality in the intensive care unit.
    Intensive Care Med 2023.


more..

Privacy Policy